301 related articles for article (PubMed ID: 34507029)
1. Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?
Wei Z; Chai H; Chen Y; Cheng Y; Liu X
Curr Opin Pharmacol; 2021 Oct; 60():291-297. PubMed ID: 34507029
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
Nadeeshani H; Li J; Ying T; Zhang B; Lu J
J Adv Res; 2022 Mar; 37():267-278. PubMed ID: 35499054
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
Yamaguchi S; Irie J; Mitsuishi M; Uchino Y; Nakaya H; Takemura R; Inagaki E; Kosugi S; Okano H; Yasui M; Tsubota K; Hayashi K; Yoshino J; Itoh H
Endocr J; 2024 Feb; 71(2):153-169. PubMed ID: 38191197
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
Katayoshi T; Uehata S; Nakashima N; Nakajo T; Kitajima N; Kageyama M; Tsuji-Naito K
Sci Rep; 2023 Feb; 13(1):2786. PubMed ID: 36797393
[TBL] [Abstract][Full Text] [Related]
5. NAD
Yoshino J; Baur JA; Imai SI
Cell Metab; 2018 Mar; 27(3):513-528. PubMed ID: 29249689
[TBL] [Abstract][Full Text] [Related]
6. Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration.
Kuerec AH; Wang W; Yi L; Tao R; Lin Z; Vaidya A; Pendse S; Thasma S; Andhalkar N; Avhad G; Kumbhar V; Maier AB
Mech Ageing Dev; 2024 Apr; 218():111917. PubMed ID: 38430946
[TBL] [Abstract][Full Text] [Related]
7. β-Nicotinamide Mononucleotide, an Anti-Aging Candidate Compound, Is Retained in the Body for Longer than Nicotinamide in Rats.
Kawamura T; Mori N; Shibata K
J Nutr Sci Vitaminol (Tokyo); 2016; 62(4):272-276. PubMed ID: 27725413
[TBL] [Abstract][Full Text] [Related]
8. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
Song Q; Zhou X; Xu K; Liu S; Zhu X; Yang J
Adv Nutr; 2023 Nov; 14(6):1416-1435. PubMed ID: 37619764
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells.
Ru M; Wang W; Zhai Z; Wang R; Li Y; Liang J; Kothari D; Niu K; Wu X
Food Funct; 2022 Jul; 13(14):7507-7519. PubMed ID: 35678708
[TBL] [Abstract][Full Text] [Related]
10. Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging.
Rahman SU; Qadeer A; Wu Z
Aging Dis; 2024 Apr; 15(2):565-583. PubMed ID: 37548938
[TBL] [Abstract][Full Text] [Related]
11. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions.
Soma M; Lalam SK
Mol Biol Rep; 2022 Oct; 49(10):9737-9748. PubMed ID: 35441939
[TBL] [Abstract][Full Text] [Related]
12. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Yi L; Maier AB; Tao R; Lin Z; Vaidya A; Pendse S; Thasma S; Andhalkar N; Avhad G; Kumbhar V
Geroscience; 2023 Feb; 45(1):29-43. PubMed ID: 36482258
[TBL] [Abstract][Full Text] [Related]
14. Metabolic engineering of Escherichia coli for biosynthesis of β-nicotinamide mononucleotide from nicotinamide.
Liu Y; Yasawong M; Yu B
Microb Biotechnol; 2021 Nov; 14(6):2581-2591. PubMed ID: 34310854
[TBL] [Abstract][Full Text] [Related]
15. Effect of Exercise and Oral Niacinamide Mononucleotide on Improving Mitochondrial Autophagy in Alzheimer's Disease.
Wu W; Yuan S; Tang Y; Meng X; Peng M; Hu Z; Liu W
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447179
[TBL] [Abstract][Full Text] [Related]
16. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
Kahn B; Borrelli M; Libby T
J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
Irie J; Inagaki E; Fujita M; Nakaya H; Mitsuishi M; Yamaguchi S; Yamashita K; Shigaki S; Ono T; Yukioka H; Okano H; Nabeshima YI; Imai SI; Yasui M; Tsubota K; Itoh H
Endocr J; 2020 Feb; 67(2):153-160. PubMed ID: 31685720
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic perspective of NAD
Iqbal T; Nakagawa T
Biochem Biophys Res Commun; 2024 Apr; 702():149590. PubMed ID: 38340651
[TBL] [Abstract][Full Text] [Related]
19. [Aging and homeostasis. Age-associated diseases and clinical application of NMN(Nicotinamide Mononucleotide).].
Irie J; Itoh H
Clin Calcium; 2017; 27(7):983-990. PubMed ID: 28649105
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.
Mills KF; Yoshida S; Stein LR; Grozio A; Kubota S; Sasaki Y; Redpath P; Migaud ME; Apte RS; Uchida K; Yoshino J; Imai SI
Cell Metab; 2016 Dec; 24(6):795-806. PubMed ID: 28068222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
